SLL
Supportive Care and Other Tools for Managing Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
In patients who received prior chronic lymphocytic leukemia/small lymphocytic lymphoma-directed therapy but require ...
MARCH 10, 2025
FDA Approves Copiktra for Relapsed or Refractory CLL, SLL
Duvelisib is an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first approved dual inhibitor of ...
SEPTEMBER 29, 2018
Load more